Last Updated: June 22, 2026

PROAIR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Proair patents expire, and what generic alternatives are available?

Proair is a drug marketed by Teva Branded Pharm and is included in two NDAs.

The generic ingredient in PROAIR is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proair

A generic version of PROAIR was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PROAIR?
  • What are the global sales for PROAIR?
  • What is Average Wholesale Price for PROAIR?
Summary for PROAIR
US Patents:0
Applicants:1
NDAs:2
Drug Prices: Drug price information for PROAIR
Drug Sales Revenues: Drug sales revenues for PROAIR
What excipients (inactive ingredients) are in PROAIR?PROAIR excipients list
DailyMed Link:PROAIR at DailyMed

US Patents and Regulatory Information for PROAIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636-002 Dec 21, 2018 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Branded Pharm PROAIR HFA albuterol sulfate AEROSOL, METERED;INHALATION 021457-001 Oct 29, 2004 AB2 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva Branded Pharm PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636-001 Mar 31, 2015 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.